Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when targeting The Plant Journal or deciding whether a plant-science manuscript fits this venue. Encodes the journal's fit, the mechanistic gene-to-function and molecular-rigor bar, evidence and data-deposition expectations, house style, official-submission re-check, and desk-reject heuristics.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
The Plant Journal, published for the Society for Experimental Biology by Wiley, is a plant-science journal focused on the molecular, cellular, biochemical, and genetic mechanisms that govern plant biology — how genes, proteins, metabolites, and regulatory networks produce plant function. Its defining expectation is rigorous mechanistic evidence: a gene-to-function study that establishes how something works, supported by genetics, biochemistry, and cell biology, not a phenotype with a plausible candidate. A descriptive or whole-organism/ecological observation with no resolved molecular mechanism fits an ecology/physiology journal better. This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current author guidelines. Before submitting, re-check the live The Plant Journal author guidance.
new-phytologist and needs the
molecular-mechanism versus ecology/physiology-breadth distinction made explicit.../../resources/source-basis.md and
../../resources/official-source-map.md; start from the official source anchors, then
cite the current The Plant Journal page you checked.new-phytologist.the-plant-cell.nature-plants.field-crops-research.nature-communications or science-advances.[Fit] High / Medium / Low (one-line reason)
[Target] The Plant Journal
[Topic tags] <2–3 closest molecular/genetic plant topics>
[Mechanism] <the resolved gene-to-function chain and its evidence>
[Method/evidence] <do genetics + biochemistry + validation clear The Plant Journal's bar?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / accession deposition / material availability / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。